BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27221971)

  • 41. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lactic acidosis and the relationship with metformin usage: Case reports.
    Huang W; Castelino RL; Peterson GM
    Medicine (Baltimore); 2016 Nov; 95(46):e4998. PubMed ID: 27861334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metformin-associated lactic acidosis: case reports and literature review.
    Chang CT; Chen YC; Fang JT; Huang CC
    J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Proposal for the modification of metformin use in patients with chronic kidney disease].
    Balogh Z; Mátyus J
    Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refining metformin prescribing in New Zealand.
    Jayathissa S; Dixon P; Bruce R; Reith D
    N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.
    Bell S; Farran B; McGurnaghan S; McCrimmon RJ; Leese GP; Petrie JR; McKeigue P; Sattar N; Wild S; McKnight J; Lindsay R; Colhoun HM; Looker H
    BMC Nephrol; 2017 May; 18(1):163. PubMed ID: 28526011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lactic acidosis induced by metformin: incidence, management and prevention.
    Lalau JD
    Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lactic acidosis. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus.
    DePalo VA; Mailer K; Yoburn D; Crausman RS
    Geriatrics; 2005 Nov; 60(11):36, 39-41. PubMed ID: 16287340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
    Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
    Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin associated lactic acidosis (MALA): clinical profiling and management.
    Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
    J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study.
    Zemedikun DT; Gokhale K; Chandan JS; Cooper J; Lord JM; Filer A; Falahee M; Nirantharakumar K; Raza K
    Rheumatology (Oxford); 2021 Dec; 60(12):5567-5575. PubMed ID: 33590842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
    Shi Q; Liu S; Fonseca VA; Thethi TK; Shi L
    BMJ Open; 2019 Jul; 9(7):e024954. PubMed ID: 31366635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
    Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.
    Yang A; Shi M; Wu H; Lau ESH; Ma RCW; Kong APS; So WY; Luk AOY; Chan JCN; Chow E
    Diabetologia; 2021 Aug; 64(8):1760-1765. PubMed ID: 33844069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metformin and surgery before general anaesthesia].
    Lauritzen E; Jensen DH; Bonde C; Beck-Nielsen H
    Ugeskr Laeger; 2018 Dec; 180(51):. PubMed ID: 30618362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.
    Fralick M; Schneeweiss S; Redelmeier DA; Razak F; Gomes T; Patorno E
    Diabetes Obes Metab; 2021 Oct; 23(10):2320-2328. PubMed ID: 34169619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.